Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

TVTXTVTX
Showing 7 of 9 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in TRAVERE THERAPEUTICS INC

Yes. BNP Paribas Financial Markets holds 1,156,960 shares of TVTX (Travere Therapeutics), worth $65.7M, as of its Q2 2026 13F filing. It increased the position from 109,382 shares in Q1 2026. BNP Paribas Financial Markets has held TVTX since Q4 2024, across 7 quarterly 13F filings.

Current Value

$65.7M

Current Shares

1.2M

Total Value Change

+$44.7M

Total Shares Change

-52,850

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+957.7%
$65.7M0.0%$56.81
48
2026-Q1
Decreased
109,382
-83.6%
$3.2M0.0%$29.71
0
2025-Q4
Increased
665,795
+17.7%
$25.4M0.0%$38.21
33
2025-Q3
Increased
565,597
+223.1%
$13.5M0.0%$23.90
45
2025-Q2
Increased
175,033
+19.0%
$2.6M0.0%$14.80
31
2025-Q1
Decreased
147,114
-87.8%
$2.6M0.0%$17.92
0
2024-Q4
New
1.2M
-
$21.1M0.0%$17.42
39

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used